Blood Donor RBC Genotyping at the National Advisory Unit on Immunohematology at Oslo University Hospital
Inger Margit Alm, Hoyi Wong, Monica Stensrud, Geir Tomter, Mette S Bævre, Çiğdem Akalın Akkök, Chak-Sum Ho · 2025
Read Blood Donor RBC Genotyping at the National Advisory Unit on Immunohematology at Oslo University Hospital by Inger Margit Alm, Hoyi Wong, Monica Stensrud, Geir Tomter, Mette S Bævre, Çiğdem Akalın Akkök, Chak-Sum Ho (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12731193.txt.
Description
Background: Blood transfusion has an essential place in the treatment of several patient groups but entails alloimmunization risk. The provision of phenotype-matched packed red blood cell concentrates (PRBCCs) is recommended for preventing alloimmunization in lifetime transfusion-dependent patients, while antigen-negative PRBCCs are a prerequisite for patients that already have blood group antibodies against clinically significant antigens.
Catalog record
| CREATOR | Inger Margit Alm, Hoyi Wong, Monica Stensrud, Geir Tomter, Mette S Bævre, Çiğdem Akalın Akkök, Chak-Sum Ho |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |